Atlas Trials

A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting

Clinical trial NCT02546869 · WITHDRAWN

Trial details

NCT number
NCT02546869
Sponsor
Hoffmann-La Roche
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2015-09-29
Primary completion
2016-06-29
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.